We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty, food and beverage industry. BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty, food and beverage industry.
HENDERSON, NV -- February 2, 2023 -- InvestorsHub NewsWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce that it has entered into a non-binding letter of intent...
Henderson, NV -- November 22, 2022 -- InvestorsHub NewsWire -- MFusion infuses copper metal ions directly into every sub-bundle of fabric, allowing for 100% copper coverage. The majority...
Despite the markets being in a funk over the last few months and it being the dog days of summer, companies of all sizes are still making moves which they hope will end in windfalls for management...
HENDERSON, NV -- July 25, 2022 -- InvestorsHub NewsWire -- BioLife Sciences Inc. (OTCPK: BLFE) (the "Company" or BioLife), announced today the launch of BioLife Copper-Infused...
The world has seen some odd and challenging times in recent years. Those worried about the recent drop in stocks should consider a few things to keep the retreat in perspective because...
The winds of change are blowing in health care and nothing put an exclamation point on it like COVID-19. Fact is that a trend shift was already in motion widening the divide between how...
If you’ve ever bought a plant that comes in a plastic pot with holes in the bottom, you’re aware of what a mess they can be and that one of the first things you need to do is get it...
There are certain nutrients that are essential to live on Earth, albeit a human or a tomato plant. One of those nutrients is copper. What is known today about utilizing copper to revolutionize the...
Henderson, NV -- February 08, 2022 -- InvestorsHub NewsWire -- BioLife Sciences (OTCPK: BLFE) is pleased to announce the launching of a new life sciences division, aimed at honing in on...
2021 was a huge year for merger and acquisitions, with the total value of deals not only crossing $2 trillion for the first time ever, but blowing passed it at an amazing $2.6 trillion across...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 165111 | 1.0E-6 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 1218488 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 613849 | 1.0E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 514028 | 1.0E-6 | CS |
52 | -0.000199 | -99.5 | 0.0002 | 0.0002 | 1.0E-6 | 4421668 | 0.00010662 | CS |
156 | -1.909999 | -99.999947644 | 1.91 | 2.15 | 1.0E-6 | 9666667 | 0.00849597 | CS |
260 | -0.002299 | -99.9565217391 | 0.0023 | 4.33 | 1.0E-6 | 6719344 | 0.01547597 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions